Logo
x

Search

Subscribe Now

Roche

Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment

Roche’s Tecentriq Hybreza Receives the US FDA’s Approval for Cancer Treatment

  • September 13, 2024
Roche Reports the P-II (FENopta) Study Data of Fenebrutinib for Treating Relapsing Multiple Sclerosis (RMS)

Roche Reports the P-II (FENopta) Study Data of Fenebrutinib for Treating Relapsing Multiple Sclerosis (RMS)

  • September 4, 2024
Roche’s PiaSky Receives the EC’s Approval to Treat Paroxysmal Nocturnal Haemoglobinuria (PNH)

Roche’s PiaSky Receives the EC’s Approval to Treat Paroxysmal Nocturnal Haemoglobinuria (PNH)

  • August 27, 2024
Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)

Roche’s Vabysmo (Faricimab) Receives the EC’s Approval to Treat Retinal Vein Occlusion (RVO)

  • July 30, 2024
Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)

Roche Reports the P-III (RHONE-X) Study Data of Vabysmo for the Treatment of Diabetic Macular Edema (DME)

  • July 18, 2024
Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity

Roche Reports the P-I (CT-996-201) Study Data of CT-996 for Treating Obesity

  • July 17, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.